Publications

Our engaging podcast and video series, "At CEEntre Stage," is a valuable resource for professionals and legal advisors seeking in-depth insights into various Corporate and M&A topics. Our series caters to diverse businesses in Central and Eastern Europe, providing comprehensive coverage of the ongoing challenges they face. Half-hour moderated discussions with legal experts and industry leaders allow us to gain valuable insights into their vision for the future, the challenges they face, and ways to improve their businesses. We also provide guidance on navigating legal complexities and avoiding potential traps, ensuring our listeners receive contextualized insights into the region's distinctive business landscape and regulatory environment. Our comprehensive coverage of various industries and their ongoing challenges makes "At CEEntre Stage" an essential resource for staying ahead of the curve in today's fast-paced economy. The podcast covers relevant Corporate and M&A topics from W&I insurances, FDI to ESOP, joint ventures, financing and ESG. Tune in to "At CEEntre Stage" today and stay informed on the latest insights and trends in the world of corporate law and M&A.

Despite the war with Russia, Ukraine works harder than ever to align its legislation with that of the EU, in a bid to accelerate the EU membership. In a long-awaited move, on 28 July 2022 Ukraine finally adopted the new Law on Medicines (Law) with a view of harmonising the Ukrainian pharmaceutical regulation and governance with the EU approaches. The Law is an overhaul of the Ukrainian pharmaceutical legislation, with substantial changes across most (if not all) areas of regulation (i.e. R&D, manufacturing, authorisation, circulation, licensing, state surveillance, promotion, etc.). The Law will enter into force gradually, with sufficient time for all market players to become fully prepared.

Despite the ongoing war with Russia, Ukraine is working harder than ever to align its legislation with that of the EU, in a bid to accelerate EU membership. In a long-awaited move, on 28 July 2022 Ukraine finally adopted the new Law on Medicines (the “Law”), with a view to harmonising Ukrainian pharmaceutical regulations and governance with EU approaches. The Law is an overhaul of the Ukrainian pharmaceutical legislation, with substantial changes across most if not all areas of regulation (R&D, manufacturing, authorisation, circulation, licensing, state surveillance, phar­ma­covi­gil­ance, promotion, etc.). The Law will enter into force gradually, with sufficient time for all market players to become fully prepared. 

What’s next? In a world of ever-ac­cel­er­at­ing change, staying ahead of the curve and knowing what’s next for your business or sector is essential. At CMS, we see ourselves not only as your legal advisers but also as your business partners. We work together with you to not only resolve current issues but to anticipate future challenges and innovate to meet them. With our latest publication, CMS Next, our experts will regularly offer you insights into and fresh perspectives on a range of issues that businesses have to deal with – from ESG agendas to restructuring after the pandemic or facing the digital transformation. We will also share with you more about the work that we are doing for our clients, helping them innovate, grow and mitigate risk. To be able to provide you with the best support, we immerse ourselves in your world to understand your legal needs and challenges. However, it is equally important that you know who we are and how we can work with you. So, we invite you to meet our experts and catch a glimpse of what is happening inside CMS. Enjoy reading this publication, which we will update regularly with new content. CMS Executive Team

The emergence of new and sustainable technologies

Welcome to CMS ‘On the Pulse’ video/podcast series for all Life Sciences & Healthcare professionals – legal, compliance, regulatory

Despite COVID-19 vaccines being only a few months old, we are already seeing the confiscation of counterfeit vaccines and the illicit trade of genuine vaccines. For those in the life sciences and health...

Legal questions regarding healthcare also play an important role in times of economic change. We advise numerous distinguished clients, such as established healthcare facilities in order for them to fulfil...

'Under the Microscope' takes a look back at some of the key legal developments in the Lifesciences sector in 2014 across Europe, in­clud­ing:Reg­u­lat­ory/Com­pet­i­tion­Com­pli­ance/Trans­par­ency­In­tel­lec­tu­al Prop­er­tyProduct...